How life sciences has shot up the investment agenda – Med-Tech Innovation | Latest news for the medical device industry
Andrew Aldridge, partner at Deepbridge Capital, explains how life sciences has become more attractive to investors with the COVID-19 vaccination roll-out. The past 12 [...]